½ÃÀ庸°í¼­
»óǰÄÚµå
1513324

¼¼°èÀÇ ÀǾàǰ Æ÷Àå ½ÃÀå : Á¦Ç° À¯Çüº°, Àç·á À¯Çüº° - ±âȸ ºÐ¼® ¹× »ê¾÷ ¿¹Ãø(2024-2035³â)

Pharmaceutical Packaging Market By Product, By Material type : Global Opportunity Analysis and Industry Forecast, 2024-2035

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Allied Market Research | ÆäÀÌÁö Á¤º¸: ¿µ¹® 275 Pages | ¹è¼Û¾È³» : 2-3ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    



¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

ÀǾàǰ Æ÷Àå ½ÃÀå ±Ô¸ð´Â 2023³â 1,117¾ï ´Þ·¯¿´À¸¸ç 2024³âºÎÅÍ 2035³â±îÁö 6.3%ÀÇ ¿¬Æò±Õ ¼ºÀå·üÀ» º¸À̸ç 2035³â¿¡´Â 2,333¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÀǾàǰ Æ÷ÀåÀº Á¦Á¶ºÎÅÍ È¯ÀÚ »ç¿ë±îÁö ¼ö¸í Áֱ⠵¿¾È ÀǾàǰÀ» º¸°üÇÏ°í º¸È£Çϱâ À§ÇÑ ¿ë±â, ¸¶°³ ¹× ±âŸ Àç·áÀÇ ¼³°è, »ý»ê ¹× Ȱ¿ëÀ» Æ÷°ýÇÕ´Ï´Ù. ÀǾàǰ Æ÷ÀåÀº Á¦Ç°ÀÇ ¾ÈÁ¤¼º, ¹«°á¼º ¹× ¾ÈÀü¼ºÀ» º¸ÀåÇÏ´Â µ¿½Ã¿¡ Á¤È®ÇÑ Åõ¾à, ¶óº§¸µ ¹× Á¤º¸ Àü´ÞÀ» ¿ëÀÌÇÏ°Ô ÇÏ´Â µî ´Ù¾çÇÑ ±â´ÉÀ» ¼öÇàÇÕ´Ï´Ù. ÀǾàǰ Æ÷ÀåÀº Á¦Ç° ǰÁú°ú ȯÀÚ ¾ÈÀüÀ» º¸ÀåÇϱâ À§ÇØ ¾ö°ÝÇÑ ±ÔÁ¦ ¿ä°ÇÀ» ÁؼöÇØ¾ß ÇÕ´Ï´Ù. ÇÃ¶ó½ºÆ½, À¯¸®, ±Ý¼Ó, Ư¼ö Æú¸®¸Ó µî ´Ù¾çÇÑ Àç·á°¡ Æ÷ÇԵǸç, °¢ Àç·á´Â ¾à¹°°úÀÇ È£È¯¼º ¹× Á¦Ç° È¿´ÉÀ» À¯ÁöÇÏ´Â ´É·Â¿¡ µû¶ó ¼±Åõ˴ϴÙ. È¿°úÀûÀÎ ÀǾàǰ Æ÷ÀåÀº ¾àÈ¿¸¦ º¸Á¸ÇÏ°í ¿À¿°À̳ª º¯Á¶¸¦ ¹æÁöÇÏ¿© °øÁß º¸°ÇÀ» º¸È£ÇÏ´Â µ¥ Áß¿äÇÑ ¿ªÇÒÀ» ÇÕ´Ï´Ù. Á¦¾à ¾÷°è¿¡¼­´Â ȯÀÚ Âü¿©¿Í Á¦Ç° ½Äº°À» °­È­Çϱâ À§ÇÑ ½º¸¶Æ® ÆÐŰ¡ ¼Ö·ç¼ÇÀÇ µµÀÔÀÌ ±ÞÁõÇϰí ÀÖ½À´Ï´Ù. ±â¾÷µéÀº Á¦Ç°À» ÃßÀûÇϰí, ȯÀÚ¿Í ¼ÒÅëÇϸç, º¹¾à ¼øÀÀµµ¸¦ º¸ÀåÇϱâ À§ÇØ RFID ¹× NFC űװ¡ Æ÷ÇÔµÈ ½º¸¶Æ® ¶óº§¸µ°ú °°Àº ±â¼úÀ» Á¡Á¡ ´õ ¸¹ÀÌ µµÀÔÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ 2D ¹ÙÄÚµå¿Í RFID ű״ °ø±Þ¸Á Àü¹Ý¿¡¼­ ÆÐŰÁö¿Í ÆÈ·¹Æ®¸¦ ¸ð´ÏÅ͸µÇÏ´Â µ¥ Ȱ¿ëµÇ°í ÀÖ½À´Ï´Ù. NFC ű״ ¼ÒºñÀÚ¿Í Á÷Á¢ ¼ÒÅëÇÒ ¼ö ÀÖ´Â º¹¾à ¼øÀÀµµ¸¦ À§ÇÑ ÃÖ÷´Ü ¼Ö·ç¼ÇÀ¸·Î ºÎ»óÇϰí ÀÖ½À´Ï´Ù. ¾î¸°ÀÌ º¸È£¿ë 1Â÷ ¹× 2Â÷ Æ÷ÀåÀç´Â ¾ÈÀü¼º°ú ±ÔÁ¤ Áؼö¸¦ °­È­Çϱâ À§ÇÑ ÁöÆÛ¹é ¹× ÆÄ¿ìÄ¡ µî ´õ¿í ½º¸¶Æ®ÇÑ ±â´ÉÀ¸·Î ÁøÈ­Çϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ 3D ½Ã°¢È­ ¹× Àμ⠱â¼úÀÇ ¹ßÀüÀ¸·Î Æ÷Àå µðÀÚÀÎ ÇÁ·Î¼¼½º°¡ °£¼ÒÈ­µÇ°í Æó±â¹°ÀÌ °¨¼ÒÇϸç ÀǾàǰ Æ÷ÀåÀÇ ¼ºÀåÀ» ÁÖµµÇϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Ãß¼¼´Â ÀǾàǰ Æ÷Àå »ê¾÷¿¡¼­ ȯÀÚ Ä¡·á °á°ú¸¦ °³¼±ÇÏ°í °ø±Þ¸Á ¿î¿µÀ» ÃÖÀûÈ­Çϱâ À§ÇÑ ±â¼ú Ȱ¿ë¿¡ ´ëÇÑ °ü½ÉÀÌ Áõ°¡Çϰí ÀÖÀ½À» °­Á¶Çϸç, ÀǾàǰ Æ÷Àå ½ÃÀåÀº Á¦Ç°, Àç·á À¯Çü ¹× Áö¿ªÀ¸·Î ¼¼ºÐÈ­µË´Ï´Ù. Á¦Ç°º°·Î ½ÃÀåÀº ºñ°æ±¸ ¿ë±â, ÇÃ¶ó½ºÆ½ º´, ºí¸®½ºÅÍ Æ÷Àå, ¸¶°³, Ư¼ö ¹é, ¶óº§ µîÀ¸·Î ºÐ·ùµË´Ï´Ù. Àç·á À¯Çü¿¡ µû¶ó ½ÃÀåÀº À¯¸®, ¾Ë·ç¹Ì´½ È£ÀÏ, ÇÃ¶ó½ºÆ½ ¹× Æú¸®¸Ó, Á¾ÀÌ ¹× ÆÇÁö µîÀ¸·Î ¼¼ºÐÈ­µË´Ï´Ù. Áö¿ªº°·Î ºÏ¹Ì(¹Ì±¹, ij³ª´Ù ¹× ¸ß½ÃÄÚ), À¯·´(µ¶ÀÏ, ÇÁ¶û½º, ¿µ±¹, ÀÌÅ»¸®¾Æ, ½ºÆäÀÎ ¹× ±âŸ À¯·´), ¾Æ½Ã¾Æ ÅÂÆò¾ç(Áß±¹, ÀϺ», Àεµ, È£ÁÖ, Çѱ¹ ¹× ±âŸ ¾Æ½Ã¾Æ ÅÂÆò¾ç) ¹× LAMEA(ºê¶óÁú, ³²¾ÆÇÁ¸®Ä«, ºÏ¾ÆÇÁ¸®Ä«, Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«)¿¡¼­ ºÐ¼®µÇ¸ç ÀǾàǰ Æ÷Àå ½ÃÀå¿¡¼­ Ȱµ¿ÇÏ´Â ÁÖ¿ä ¾÷ü´Â Amcor Plc., Aptar Group, Inc., Catalent Inc., CCL Industries Inc., Becton, Dickinson and Company, Gerresheimer AG, West Pharmaceutical Services, Inc., Nipro Corporation, Berry Global Group, Inc, SCHOTT pharmaceutical packaging µîÀÔ´Ï´Ù. ÁÖ¿ä ¾÷üµéÀº °æÀï ½ÃÀå¿¡¼­ÀÇ ÀÔÁö¸¦ °­È­Çϱâ À§ÇØ Á¦Ç° Ãâ½Ã, Á¦Ç° °³¹ß, Çù¾÷, ÆÄÆ®³Ê½Ê ¹× Á¦Ç° ½ÂÀÎÀ» ÁÖ¿ä Àü·«À¸·Î äÅÃÇß½À´Ï´Ù.

ÀÌÇØ°ü°èÀÚ¸¦ À§ÇÑ ÁÖ¿ä ÀÌÁ¡

  • ÀÌ º¸°í¼­´Â 2023³âºÎÅÍ 2035³â±îÁö ÀǾàǰ Æ÷Àå ½ÃÀå ºÐ¼®ÀÇ ½ÃÀå ºÎ¹®, ÇöÀç µ¿Çâ, ÃßÁ¤ ¹× µ¿Ç⠺м®, ¿ªÇÐÀ» Á¤·®ÀûÀ¸·Î ºÐ¼®ÇÏ¿© ÀϹÝÀûÀÎ ÀǾàǰ Æ÷Àå ½ÃÀå ±âȸ¸¦ ½Äº°ÇÕ´Ï´Ù.
  • ½ÃÀå ÃËÁø¿äÀÎ, ½ÃÀå ¾ïÁ¦¿äÀÎ, ½ÃÀå ±âȸ¿Í °ü·ÃµÈ Á¤º¸¿Í ÇÔ²² ½ÃÀå Á¶»ç¸¦ Á¦°øÇÕ´Ï´Ù.
  • Porter's Five Forces ºÐ¼®Àº ÀÌÇØ °ü°èÀÚ°¡ ÀÌÀÍ Áß½ÉÀÇ ºñÁî´Ï½º °áÁ¤À» ³»¸®°í °ø±Þ¾÷ü¿Í °ø±Þ¾÷üÀÇ ³×Æ®¿öÅ©¸¦ °­È­ÇÒ ¼ö ÀÖµµ·Ï ±¸¸ÅÀÚ¿Í °ø±Þ¾÷üÀÇ ÀáÀç·ÂÀ» °­Á¶ÇÕ´Ï´Ù.
  • ÀǾàǰ Æ÷Àå ½ÃÀåÀÇ ¼¼ºÐÈ­¸¦ ÀÚ¼¼È÷ ºÐ¼®ÇÏ¿© ½ÃÀå ±âȸ¸¦ ÆÄ¾ÇÇÒ ¼ö ÀÖ½À´Ï´Ù.
  • °¢ Áö¿ªÀÇ ÁÖ¿ä ±¹°¡´Â ¼¼°è ½ÃÀå¿¡ ´ëÇÑ ¼öÀÍ ±â¿©µµ¿¡ µû¶ó ¸ÅÇεǾî ÀÖ½À´Ï´Ù.
  • ½ÃÀå ±â¾÷ÀÇ Æ÷Áö¼Å´×Àº º¥Ä¡¸¶Å·À» ¿ëÀÌÇÏ°Ô ÇÏ°í ½ÃÀå ±â¾÷ÀÇ ÇöÀç À§Ä¡¸¦ ¸íÈ®ÇÏ°Ô ÀÌÇØÇÒ ¼ö ÀÖ½À´Ï´Ù.
  • ÀÌ º¸°í¼­¿¡´Â Áö¿ª ¹× ¼¼°è ÀǾàǰ Æ÷Àå ½ÃÀå µ¿Çâ, ÁÖ¿ä ±â¾÷, ½ÃÀå ºÎ¹®, ÀÀ¿ë ºÐ¾ß ¹× ½ÃÀå ¼ºÀå Àü·«¿¡ ´ëÇÑ ºÐ¼®ÀÌ Æ÷ÇԵǾî ÀÖ½À´Ï´Ù.

±âŸ ÇýÅÃÀº ´ÙÀ½°ú °°½À´Ï´Ù.

  • ºÐ±âº° °»½Å ¹×*(±â¾÷¿ë ¶óÀ̼±½º·Î¸¸ Á¦°øµÇ¸ç, Ç¥½ÃµÈ °¡°ÝÀ¸·Î Á¦°øµÊ)
  • ±¸¸Å Àü ¶Ç´Â ±¸¸Å ÈÄ ¼±ÅÃÇÑ ±â¾÷ °³¿ä 5°³¸¦ Ãß°¡, ¹«·á °»½ÅÀ¸·Î Ãß°¡
  • 5°³ ¹× ¿£ÅÍÇÁ¶óÀÌÁî »ç¿ëÀÚ ¶óÀ̼±½º ±¸¸Å ½Ã Ãâ½Ã ¿¹Á¤ ¹öÀüÀÌ ¹«·á·Î Á¦°ø
  • 16½Ã°£ÀÇ ¾Ö³Î¸®½ºÆ® Áö¿ø*(±¸¸Å ÈÄ º¸°í¼­ È®ÀÎ ½Ã Ãß°¡ µ¥ÀÌÅÍ ¿ä±¸»çÇ×ÀÌ ¹ß°ßµÉ °æ¿ì, 16½Ã°£ µ¿¾È ¾Ö³Î¸®½ºÆ®ÀÇ Áö¿øÀ» ¹Þ¾Æ Áú¹® ¹× ÆÇ¸Å ÈÄ ¹®ÀǸ¦ ÇØ°áÇÒ ¼ö ÀÖÀ½)
  • 15% ¹«·á Ä¿½ºÅ͸¶ÀÌ¡*(º¸°í¼­ ¹üÀ§ ¶Ç´Â ºÎ¹®ÀÌ °í°´ÀÇ ¿ä±¸ »çÇ×°ú ÀÏÄ¡ÇÏÁö ¾Ê´Â °æ¿ì 15%´Â 3 ¿µ¾÷ÀÏ ¹«·á ÀÛ¾÷¿¡ ÇØ´çÇϸç ÇÑ ¹ø¸¸ Àû¿ëµÊ)
  • »ç¿ëÀÚ ¶óÀ̼±½º ¹× ¿£ÅÍÇÁ¶óÀÌÁî »ç¿ëÀÚ ¶óÀ̼±½º¿¡ ´ëÇÑ ¹«·á µ¥ÀÌÅÍÆÑ.(º¸°í¼­ÀÇ ¿¢¼¿ ¹öÀü)
  • ÀÌ 6-12°³¿ù ÀÌ»ó µÈ °æ¿ì ¹«·á ¾÷µ¥ÀÌÆ® º¸°í¼­.
  • *24½Ã°£ ¿ì¼± ´ëÀÀ* ¹«·á
  • ¾÷°è ¾÷µ¥ÀÌÆ® ¹× ¹é¼­.
    Pharmaceutical Packaging Market-IMG1

º» º¸°í¼­¿¡¼­ °¡´ÉÇÑ Ä¿½ºÅ͸¶ÀÌ¡(Ãß°¡ ºñ¿ë ¹× ÀÏÁ¤ÀÌ ÇÊ¿äÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ ³»¿ëÀº ¿µ¾÷ ´ã´çÀÚ¿¡°Ô ¹®ÀÇ ¹Ù¶ø´Ï´Ù)

  • ±ÔÁ¦ °¡À̵å¶óÀÎ
  • °í°´ÀÇ °ü½É»ç¿¡ µû¸¥ ±â¾÷ °³¿ä Ãß°¡
  • ±¹°¡ ¶Ç´Â Áö¿ª ºÐ¼® - ½ÃÀå ±Ô¸ð ¹× ¿¹Ãø Ãß°¡
  • ±â¾÷ °³¿ä È®Àå
  • °ú°Å ½ÃÀå µ¥ÀÌÅÍ
  • ÁÖ¿ä Ç÷¹À̾îÀÇ ¼¼ºÎ Á¤º¸(À§Ä¡, ¿¬¶ôó, °ø±Þ¾÷ü/º¥´õ ³×Æ®¿öÅ© µî Æ÷ÇÔ, ¿¢¼¿ Çü½Ä)

¸ñÂ÷

Á¦1Àå ¼Ò°³

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå ½ÃÀå °³¿ä

  • ½ÃÀå Á¤ÀÇ¿Í ¹üÀ§
  • ÁÖ¿ä Á¶»ç °á°ú
    • ¿µÇâ¿äÀÎ
    • ÁÖ¿ä ÅõÀÚ ±âȸ
  • Porter's Five Forces ºÐ¼®
  • ½ÃÀå ¿ªÇÐ
    • ¼ºÀå ÃËÁø¿äÀÎ
    • ¼ºÀå ¾ïÁ¦¿äÀÎ
    • ±âȸ

Á¦4Àå ÀǾàǰ Æ÷Àå ½ÃÀå : Á¦Ç°º°

  • °³¿ä
  • ºñ°æ±¸ ¿ë±â
  • ÇÃ¶ó½ºÆ½ º¸Æ²
  • ºí¸®½ºÅÍ Æ÷Àå
  • Ư¼ö ºÀÅõ
  • ¸¶°³
  • ¶óº§
  • ±âŸ

Á¦5Àå ÀǾàǰ Æ÷Àå ½ÃÀå : ¼ÒÀç À¯Çüº°

  • °³¿ä
  • À¯¸®
  • ¾Ë·ç¹Ì´½¹Ú
  • ÇÃ¶ó½ºÆ½°ú Æú¸®¸Ó
  • Á¾ÀÌ¿Í ÆÇÁö
  • ±âŸ

Á¦6Àå ÀǾàǰ Æ÷Àå ½ÃÀå : Áö¿ªº°

  • °³¿ä
  • ºÏ¹Ì
    • ¹Ì±¹
    • ij³ª´Ù
    • ¸ß½ÃÄÚ
  • À¯·´
    • µ¶ÀÏ
    • ÇÁ¶û½º
    • ¿µ±¹
    • ÀÌÅ»¸®¾Æ
    • ½ºÆäÀÎ
    • ±âŸ
  • ¾Æ½Ã¾ÆÅÂÆò¾ç
    • ÀϺ»
    • Áß±¹
    • Àεµ
    • È£ÁÖ
    • Çѱ¹
    • ±âŸ
  • ¶óƾ¾Æ¸Þ¸®Ä«, Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
    • ºê¶óÁú
    • »ç¿ìµð¾Æ¶óºñ¾Æ
    • ³²¾ÆÇÁ¸®Ä«°øÈ­±¹
    • ±âŸ

Á¦7Àå °æÀï »óȲ

  • ¼Ò°³
  • ÁÖ¿ä ¼º°ø Àü·«
  • ÁÖ¿ä 10°³»ç Á¦Ç° ¸ÅÇÎ
  • °æÀï ´ë½Ãº¸µå
  • °æÀï È÷Æ®¸Ê
  • ÁÖ¿ä ±â¾÷ÀÇ Æ÷Áö¼Å´×, 2023³â

Á¦8Àå ±â¾÷ °³¿ä

  • Amcor plc.
  • Aptar Group, Inc.
  • Catalent Inc.
  • CCL Industries Inc.
  • BD(Becton, Dickinson and Company)
  • Gerresheimer AG
  • West Pharmaceutical Services, Inc.
  • Nipro Corporation
  • Berry Global Group, Inc
  • SCHOTT Pharmaceutical Packaging
ksm 24.07.19

The pharmaceutical packaging market was valued at $111.7 billion in 2023 and is estimated to reach $233.3 billion by 2035, exhibiting a CAGR of 6.3% from 2024 to 2035. Pharmaceutical packaging encompasses the design, production, and utilization of containers, closures, and other materials intended to house and protect pharmaceutical products throughout their lifecycle, from manufacturing to patient use. It serves multiple functions, including ensuring product stability, integrity, and safety, while also facilitating accurate dosing, labeling, and information dissemination. Pharmaceutical packaging must comply with stringent regulatory requirements to guarantee product quality and patient safety. It encompasses a wide range of materials, such as plastics, glass, metals, and specialized polymers, each chosen for its compatibility with the medication and its ability to maintain product efficacy. Effective pharmaceutical packaging plays a crucial role in safeguarding public health by preserving medication potency and preventing contamination or tampering.The pharmaceutical industry is witnessing a surge in the adoption of smart packaging solutions aimed at enhancing patient engagement and product identification. Companies are increasingly incorporating technologies such as smart labeling with RFID and NFC tags to track products, engage with patients, and ensure medication adherence. Additionally, 2D barcodes and RFID tags are being utilized to monitor packages and pallets across the supply chain. NFC tags have emerged as a cutting-edge solution for medication adherence, enabling direct communication with consumers. Child-resistant primary and secondary packaging is evolving with smarter features, including Ziplock bags and pouches for enhanced safety and compliance. Furthermore, advancements in 3D visualization and printing techniques are streamlining packaging design processes, reducing waste, and driving growth in pharmaceutical packaging. This trend highlights an increasing focus on utilizing technology to enhance patient outcomes and optimize supply chain operations within the pharmaceutical packaging industry.The pharmaceutical packaging market is segmented into product, material type, and region. By product, the market is classified into parenteral containers, plastic bottles, blister packaging, closures, specialty bags, labels, and others. On the basis of material type, the market is fragmented into glass, aluminum foils, plastics and polymers, paper and paperboards, and others. Region-wise, it is analyzed across North America (U.S., Canada, and Mexico), Europe (Germany, France, UK, Italy, Spain, and rest of Europe), Asia-Pacific (China, Japan, India, Australia, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, North Africa, Middle East & Africa).The key players that operate in the pharmaceutical packaging market are Amcor Plc., Aptar Group, Inc., Catalent Inc., CCL Industries Inc., Becton, Dickinson and Company, Gerresheimer AG, West Pharmaceutical Services, Inc., Nipro Corporation, Berry Global Group, Inc and SCHOTT pharmaceutical packaging. The key players have adopted product launch, product development, collaboration, partnership and product approval as the key strategies to strengthen their foothold in the competitive market.

Key Benefits For Stakeholders

  • This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the pharmaceutical packaging market analysis from 2023 to 2035 to identify the prevailing pharmaceutical packaging market opportunities.
  • The market research is offered along with information related to key drivers, restraints, and opportunities.
  • Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
  • In-depth analysis of the pharmaceutical packaging market segmentation assists to determine the prevailing market opportunities.
  • Major countries in each region are mapped according to their revenue contribution to the global market.
  • Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
  • The report includes the analysis of the regional as well as global pharmaceutical packaging market trends, key players, market segments, application areas, and market growth strategies.

Additional benefits you will get with this purchase are:

  • Quarterly Update and* (only available with a corporate license, on listed price)
  • 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
  • Free Upcoming Version on the Purchase of Five and Enterprise User License.
  • 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
  • 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
  • Free data Pack on the Five and Enterprise User License. (Excel version of the report)
  • Free Updated report if the report is 6-12 months old or older.
  • 24-hour priority response*
  • Free Industry updates and white papers.
    Pharmaceutical Packaging Market - IMG1
    Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)
  • Regulatory Guidelines
  • Additional company profiles with specific to client's interest
  • Additional country or region analysis- market size and forecast
  • Expanded list for Company Profiles
  • Historic market data
  • Key player details (including location, contact details, supplier/vendor network etc. in excel format)

Key Market Segments

By Product

  • Parenteral Container
  • Plastic Bottle
  • Blister packing
  • Specialty Bags
  • Closures
  • Labels
  • Others

By Material type

  • Glass
  • Aluminum Foils
  • Plastics and Polymers
  • Paper and Paperboards
  • Others

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • Saudi Arabia
    • South Africa
    • Rest of LAMEA

Key Market Players:

    • Amcor plc.
    • Aptar Group, Inc.
    • Catalent Inc.
    • CCL Industries Inc.
    • BD (Becton, Dickinson and Company)
    • Gerresheimer AG
    • West Pharmaceutical Services, Inc.
    • Nipro Corporation
    • Berry Global Group, Inc
    • SCHOTT Pharmaceutical Packaging

TABLE OF CONTENTS

CHAPTER 1: INTRODUCTION

  • 1.1. Report description
  • 1.2. Key market segments
  • 1.3. Key benefits to the stakeholders
  • 1.4. Research methodology
    • 1.4.1. Primary research
    • 1.4.2. Secondary research
    • 1.4.3. Analyst tools and models

CHAPTER 2: EXECUTIVE SUMMARY

  • 2.1. CXO perspective

CHAPTER 3: MARKET OVERVIEW

  • 3.1. Market definition and scope
  • 3.2. Key findings
    • 3.2.1. Top impacting factors
    • 3.2.2. Top investment pockets
  • 3.3. Porter's five forces analysis
  • 3.4. Market dynamics
    • 3.4.1. Drivers
    • 3.4.2. Restraints
    • 3.4.3. Opportunities

CHAPTER 4: PHARMACEUTICAL PACKAGING MARKET, BY PRODUCT

  • 4.1. Overview
    • 4.1.1. Market size and forecast
  • 4.2. Parenteral Container
    • 4.2.1. Key market trends, growth factors and opportunities
    • 4.2.2. Market size and forecast, by region
    • 4.2.3. Market share analysis by country
  • 4.3. Plastic Bottle
    • 4.3.1. Key market trends, growth factors and opportunities
    • 4.3.2. Market size and forecast, by region
    • 4.3.3. Market share analysis by country
  • 4.4. Blister packing
    • 4.4.1. Key market trends, growth factors and opportunities
    • 4.4.2. Market size and forecast, by region
    • 4.4.3. Market share analysis by country
  • 4.5. Specialty Bags
    • 4.5.1. Key market trends, growth factors and opportunities
    • 4.5.2. Market size and forecast, by region
    • 4.5.3. Market share analysis by country
  • 4.6. Closures
    • 4.6.1. Key market trends, growth factors and opportunities
    • 4.6.2. Market size and forecast, by region
    • 4.6.3. Market share analysis by country
  • 4.7. Labels
    • 4.7.1. Key market trends, growth factors and opportunities
    • 4.7.2. Market size and forecast, by region
    • 4.7.3. Market share analysis by country
  • 4.8. Others
    • 4.8.1. Key market trends, growth factors and opportunities
    • 4.8.2. Market size and forecast, by region
    • 4.8.3. Market share analysis by country

CHAPTER 5: PHARMACEUTICAL PACKAGING MARKET, BY MATERIAL TYPE

  • 5.1. Overview
    • 5.1.1. Market size and forecast
  • 5.2. Glass
    • 5.2.1. Key market trends, growth factors and opportunities
    • 5.2.2. Market size and forecast, by region
    • 5.2.3. Market share analysis by country
  • 5.3. Aluminum Foils
    • 5.3.1. Key market trends, growth factors and opportunities
    • 5.3.2. Market size and forecast, by region
    • 5.3.3. Market share analysis by country
  • 5.4. Plastics and Polymers
    • 5.4.1. Key market trends, growth factors and opportunities
    • 5.4.2. Market size and forecast, by region
    • 5.4.3. Market share analysis by country
  • 5.5. Paper and Paperboards
    • 5.5.1. Key market trends, growth factors and opportunities
    • 5.5.2. Market size and forecast, by region
    • 5.5.3. Market share analysis by country
  • 5.6. Others
    • 5.6.1. Key market trends, growth factors and opportunities
    • 5.6.2. Market size and forecast, by region
    • 5.6.3. Market share analysis by country

CHAPTER 6: PHARMACEUTICAL PACKAGING MARKET, BY REGION

  • 6.1. Overview
    • 6.1.1. Market size and forecast By Region
  • 6.2. North America
    • 6.2.1. Key market trends, growth factors and opportunities
    • 6.2.2. Market size and forecast, by Product
    • 6.2.3. Market size and forecast, by Material type
    • 6.2.4. Market size and forecast, by country
      • 6.2.4.1. U.S.
      • 6.2.4.1.1. Market size and forecast, by Product
      • 6.2.4.1.2. Market size and forecast, by Material type
      • 6.2.4.2. Canada
      • 6.2.4.2.1. Market size and forecast, by Product
      • 6.2.4.2.2. Market size and forecast, by Material type
      • 6.2.4.3. Mexico
      • 6.2.4.3.1. Market size and forecast, by Product
      • 6.2.4.3.2. Market size and forecast, by Material type
  • 6.3. Europe
    • 6.3.1. Key market trends, growth factors and opportunities
    • 6.3.2. Market size and forecast, by Product
    • 6.3.3. Market size and forecast, by Material type
    • 6.3.4. Market size and forecast, by country
      • 6.3.4.1. Germany
      • 6.3.4.1.1. Market size and forecast, by Product
      • 6.3.4.1.2. Market size and forecast, by Material type
      • 6.3.4.2. France
      • 6.3.4.2.1. Market size and forecast, by Product
      • 6.3.4.2.2. Market size and forecast, by Material type
      • 6.3.4.3. UK
      • 6.3.4.3.1. Market size and forecast, by Product
      • 6.3.4.3.2. Market size and forecast, by Material type
      • 6.3.4.4. Italy
      • 6.3.4.4.1. Market size and forecast, by Product
      • 6.3.4.4.2. Market size and forecast, by Material type
      • 6.3.4.5. Spain
      • 6.3.4.5.1. Market size and forecast, by Product
      • 6.3.4.5.2. Market size and forecast, by Material type
      • 6.3.4.6. Rest of Europe
      • 6.3.4.6.1. Market size and forecast, by Product
      • 6.3.4.6.2. Market size and forecast, by Material type
  • 6.4. Asia-Pacific
    • 6.4.1. Key market trends, growth factors and opportunities
    • 6.4.2. Market size and forecast, by Product
    • 6.4.3. Market size and forecast, by Material type
    • 6.4.4. Market size and forecast, by country
      • 6.4.4.1. Japan
      • 6.4.4.1.1. Market size and forecast, by Product
      • 6.4.4.1.2. Market size and forecast, by Material type
      • 6.4.4.2. China
      • 6.4.4.2.1. Market size and forecast, by Product
      • 6.4.4.2.2. Market size and forecast, by Material type
      • 6.4.4.3. India
      • 6.4.4.3.1. Market size and forecast, by Product
      • 6.4.4.3.2. Market size and forecast, by Material type
      • 6.4.4.4. Australia
      • 6.4.4.4.1. Market size and forecast, by Product
      • 6.4.4.4.2. Market size and forecast, by Material type
      • 6.4.4.5. South Korea
      • 6.4.4.5.1. Market size and forecast, by Product
      • 6.4.4.5.2. Market size and forecast, by Material type
      • 6.4.4.6. Rest of Asia-Pacific
      • 6.4.4.6.1. Market size and forecast, by Product
      • 6.4.4.6.2. Market size and forecast, by Material type
  • 6.5. LAMEA
    • 6.5.1. Key market trends, growth factors and opportunities
    • 6.5.2. Market size and forecast, by Product
    • 6.5.3. Market size and forecast, by Material type
    • 6.5.4. Market size and forecast, by country
      • 6.5.4.1. Brazil
      • 6.5.4.1.1. Market size and forecast, by Product
      • 6.5.4.1.2. Market size and forecast, by Material type
      • 6.5.4.2. Saudi Arabia
      • 6.5.4.2.1. Market size and forecast, by Product
      • 6.5.4.2.2. Market size and forecast, by Material type
      • 6.5.4.3. South Africa
      • 6.5.4.3.1. Market size and forecast, by Product
      • 6.5.4.3.2. Market size and forecast, by Material type
      • 6.5.4.4. Rest of LAMEA
      • 6.5.4.4.1. Market size and forecast, by Product
      • 6.5.4.4.2. Market size and forecast, by Material type

CHAPTER 7: COMPETITIVE LANDSCAPE

  • 7.1. Introduction
  • 7.2. Top winning strategies
  • 7.3. Product mapping of top 10 player
  • 7.4. Competitive dashboard
  • 7.5. Competitive heatmap
  • 7.6. Top player positioning, 2023

CHAPTER 8: COMPANY PROFILES

  • 8.1. Amcor plc.
    • 8.1.1. Company overview
    • 8.1.2. Key executives
    • 8.1.3. Company snapshot
    • 8.1.4. Operating business segments
    • 8.1.5. Product portfolio
    • 8.1.6. Business performance
    • 8.1.7. Key strategic moves and developments
  • 8.2. Aptar Group, Inc.
    • 8.2.1. Company overview
    • 8.2.2. Key executives
    • 8.2.3. Company snapshot
    • 8.2.4. Operating business segments
    • 8.2.5. Product portfolio
    • 8.2.6. Business performance
    • 8.2.7. Key strategic moves and developments
  • 8.3. Catalent Inc.
    • 8.3.1. Company overview
    • 8.3.2. Key executives
    • 8.3.3. Company snapshot
    • 8.3.4. Operating business segments
    • 8.3.5. Product portfolio
    • 8.3.6. Business performance
    • 8.3.7. Key strategic moves and developments
  • 8.4. CCL Industries Inc.
    • 8.4.1. Company overview
    • 8.4.2. Key executives
    • 8.4.3. Company snapshot
    • 8.4.4. Operating business segments
    • 8.4.5. Product portfolio
    • 8.4.6. Business performance
    • 8.4.7. Key strategic moves and developments
  • 8.5. BD (Becton, Dickinson and Company)
    • 8.5.1. Company overview
    • 8.5.2. Key executives
    • 8.5.3. Company snapshot
    • 8.5.4. Operating business segments
    • 8.5.5. Product portfolio
    • 8.5.6. Business performance
    • 8.5.7. Key strategic moves and developments
  • 8.6. Gerresheimer AG
    • 8.6.1. Company overview
    • 8.6.2. Key executives
    • 8.6.3. Company snapshot
    • 8.6.4. Operating business segments
    • 8.6.5. Product portfolio
    • 8.6.6. Business performance
    • 8.6.7. Key strategic moves and developments
  • 8.7. West Pharmaceutical Services, Inc.
    • 8.7.1. Company overview
    • 8.7.2. Key executives
    • 8.7.3. Company snapshot
    • 8.7.4. Operating business segments
    • 8.7.5. Product portfolio
    • 8.7.6. Business performance
    • 8.7.7. Key strategic moves and developments
  • 8.8. Nipro Corporation
    • 8.8.1. Company overview
    • 8.8.2. Key executives
    • 8.8.3. Company snapshot
    • 8.8.4. Operating business segments
    • 8.8.5. Product portfolio
    • 8.8.6. Business performance
    • 8.8.7. Key strategic moves and developments
  • 8.9. Berry Global Group, Inc
    • 8.9.1. Company overview
    • 8.9.2. Key executives
    • 8.9.3. Company snapshot
    • 8.9.4. Operating business segments
    • 8.9.5. Product portfolio
    • 8.9.6. Business performance
    • 8.9.7. Key strategic moves and developments
  • 8.10. SCHOTT Pharmaceutical Packaging
    • 8.10.1. Company overview
    • 8.10.2. Key executives
    • 8.10.3. Company snapshot
    • 8.10.4. Operating business segments
    • 8.10.5. Product portfolio
    • 8.10.6. Business performance
    • 8.10.7. Key strategic moves and developments
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦